CSR Quote, Financials, Valuation and Earnings

Equity LifeStyle Properties, Inc. has a net margin of 43.34% compared to Centerspace's net margin of 27.77%. Centerspace's return on equity of 4.38% beat Equity LifeStyle Properties, Inc.'s return on equity of 22.1%.

Centerspace has a consensus price target of $68.39, signalling upside risk potential of 8.95%. On the other hand Equity LifeStyle Properties, Inc. has an analysts' consensus of $69.26 which suggests that it could grow by 3.1%. Given that Centerspace has higher upside potential than Equity LifeStyle Properties, Inc., analysts believe Centerspace is more attractive than Equity LifeStyle Properties, Inc..

Centerspace has a beta of 0.779, which suggesting that the stock is 22.096% less volatile than S&P 500. In comparison Equity LifeStyle Properties, Inc. has a beta of 0.765, suggesting its less volatile than the S&P 500 by 23.523%.

Centerspace has a quarterly dividend of $0.77 per share corresponding to a yield of 4.91%. Equity LifeStyle Properties, Inc. offers a yield of 2.96% to investors and pays a quarterly dividend of $0.52 per share. Centerspace pays 361.12% of its earnings as a dividend. Equity LifeStyle Properties, Inc. pays out 106.66% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Centerspace quarterly revenues are $150.9M, which are smaller than Equity LifeStyle Properties, Inc. quarterly revenues of $373.9M. Centerspace's net income of $65.4M is lower than Equity LifeStyle Properties, Inc.'s net income of $103.8M. Notably, Centerspace's price-to-earnings ratio is 47.42x while Equity LifeStyle Properties, Inc.'s PE ratio is 34.78x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Centerspace is 3.10x versus 8.77x for Equity LifeStyle Properties, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Global Medical REIT, Inc. has a net margin of 43.34% compared to Centerspace's net margin of -12.47%. Centerspace's return on equity of 4.38% beat Global Medical REIT, Inc.'s return on equity of 0.41%.

Centerspace has a consensus price target of $68.39, signalling upside risk potential of 8.95%. On the other hand Global Medical REIT, Inc. has an analysts' consensus of $40.86 which suggests that it could grow by 12.99%. Given that Global Medical REIT, Inc. has higher upside potential than Centerspace, analysts believe Global Medical REIT, Inc. is more attractive than Centerspace.

Centerspace has a beta of 0.779, which suggesting that the stock is 22.096% less volatile than S&P 500. In comparison Global Medical REIT, Inc. has a beta of 1.180, suggesting its more volatile than the S&P 500 by 18.011%.

Centerspace has a quarterly dividend of $0.77 per share corresponding to a yield of 4.91%. Global Medical REIT, Inc. offers a yield of 9.13% to investors and pays a quarterly dividend of $0.75 per share. Centerspace pays 361.12% of its earnings as a dividend. Global Medical REIT, Inc. pays out 6829.27% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Centerspace quarterly revenues are $150.9M, which are larger than Global Medical REIT, Inc. quarterly revenues of $40.6M. Centerspace's net income of $65.4M is higher than Global Medical REIT, Inc.'s net income of -$5.1M. Notably, Centerspace's price-to-earnings ratio is 47.42x while Global Medical REIT, Inc.'s PE ratio is 312.68x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Centerspace is 3.10x versus 9.14x for Global Medical REIT, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Lineage, Inc. has a net margin of 43.34% compared to Centerspace's net margin of -8.13%. Centerspace's return on equity of 4.38% beat Lineage, Inc.'s return on equity of -2.03%.

Centerspace has a consensus price target of $68.39, signalling upside risk potential of 8.95%. On the other hand Lineage, Inc. has an analysts' consensus of $39.44 which suggests that it could grow by 4.24%. Given that Centerspace has higher upside potential than Lineage, Inc., analysts believe Centerspace is more attractive than Lineage, Inc..

Centerspace has a beta of 0.779, which suggesting that the stock is 22.096% less volatile than S&P 500. In comparison Lineage, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Centerspace has a quarterly dividend of $0.77 per share corresponding to a yield of 4.91%. Lineage, Inc. offers a yield of 5.58% to investors and pays a quarterly dividend of $0.53 per share. Centerspace pays 361.12% of its earnings as a dividend. Lineage, Inc. pays out 30.35% of its earnings as a dividend. Lineage, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Centerspace's is not.

Centerspace quarterly revenues are $150.9M, which are smaller than Lineage, Inc. quarterly revenues of $1.4B. Centerspace's net income of $65.4M is higher than Lineage, Inc.'s net income of -$112M. Notably, Centerspace's price-to-earnings ratio is 47.42x while Lineage, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Centerspace is 3.10x versus 1.61x for Lineage, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Symmetry Medical, Inc. has a net margin of 43.34% compared to Centerspace's net margin of --. Centerspace's return on equity of 4.38% beat Symmetry Medical, Inc.'s return on equity of --.

Centerspace has a consensus price target of $68.39, signalling upside risk potential of 8.95%. On the other hand Symmetry Medical, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Centerspace has higher upside potential than Symmetry Medical, Inc., analysts believe Centerspace is more attractive than Symmetry Medical, Inc..

Centerspace has a beta of 0.779, which suggesting that the stock is 22.096% less volatile than S&P 500. In comparison Symmetry Medical, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Centerspace has a quarterly dividend of $0.77 per share corresponding to a yield of 4.91%. Symmetry Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Centerspace pays 361.12% of its earnings as a dividend. Symmetry Medical, Inc. pays out -- of its earnings as a dividend.

Centerspace quarterly revenues are $150.9M, which are larger than Symmetry Medical, Inc. quarterly revenues of --. Centerspace's net income of $65.4M is higher than Symmetry Medical, Inc.'s net income of --. Notably, Centerspace's price-to-earnings ratio is 47.42x while Symmetry Medical, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Centerspace is 3.10x versus -- for Symmetry Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.